Litcius/Paper detail

AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury

Ying Wang, Zhiwen Liu, Shaoqun Shu, Juan Cai, Chengyuan Tang, Zheng Dong

2020Frontiers in Physiology129 citationsDOIOpen Access PDF

Abstract

Autophagy is a conserved, multistep pathway that degrades and recycles dysfunctional organelles and macromolecules to maintain cellular homeostasis. Mammalian target of rapamycin (mTOR) and adenosine-monophosphate activated-protein kinase (AMPK) are major negative and positive regulators of autophagy, respectively. In cisplatin-induced acute kidney injury (AKI) or nephrotoxicity, autophagy is rapidly induced in renal tubular epithelial cells and acts as a cytoprotective mechanism for cell survival. Both mTOR and AMPK have been implicated in the regulation of autophagy in cisplatin-induced AKI. Targeting mTOR and/or AMPK may offer effective strategies for kidney protection during cisplatin-mediated chemotherapy.

Topics & Concepts

AutophagyAMPKPI3K/AKT/mTOR pathwayCisplatinAcute kidney injuryNephrotoxicityCell biologyProtein kinase AMetforminKidneyAdenosineCancer researchChemistryAMP-activated protein kinaseRPTORULK1Programmed cell deathPharmacologyKinaseMedicineSignal transductionApoptosisBiologyInternal medicineChemotherapyBiochemistryInsulinChemotherapy-induced organ toxicity mitigationAutophagy in Disease and TherapyBiomedical Research and Pathophysiology
AMPK/mTOR Signaling in Autophagy Regulation During Cisplatin-Induced Acute Kidney Injury | Litcius